Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL907530 | 0.97 | — | — | |
| SCHEMBL1196362 | 0.97 | KDM4E (0.33) | KDM4E | |
| SCHEMBL1718218 | 0.95 | KDM4E (0.30) | KDM4E | |
| SCHEMBL3303625 | 0.81 | KDM4E (0.30) | KDM4E | |
| SCHEMBL2863020 | 0.78 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL18092904 | 0.75 | ACHE (0.33) | — | |
| SCHEMBL21315162 | 0.74 | KDM4E (0.30) | KDM4E | |
| Bromide SCHEMBL31207605 | 0.73 | TP53 (0.31) | — | |
| SCHEMBL4857537 | 0.72 | — | — | |
| Bromide SCHEMBL10551615 | 0.72 | TSHR (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1698631-B1 | IONIC LIQUID, METHOD FOR PRODUCING SAME, DOUBLE LAYER CAPACITOR COMPRISING SAME, AND LITHIUM BATTERY | NAT INST OF ADVANCED IND SCIEN (JP) | 2011-08-10 | — | — | EP | disclosed |
| US-20070099079-A1 | Ionic liquid, method for producing same, double layer capacitor comprising same, and lithium battery | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2007-05-03 | — | — | US | disclosed |
| EP-1698631-A1 | IONIC LIQUID, METHOD FOR PRODUCING SAME, DOUBLE LAYER CAPACITOR COMPRISING SAME, AND LITHIUM BATTERY | National Institute of Advanced Industrial Science and Technology (JP) | 2006-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099079-A1 | Ionic liquid, method for producing same, double layer capacitor comprising same, and lithium battery | CLCN2, CACNA1F, CACNB3 | KDM4E 2047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.